•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Cigna seeks to disqualify FTC Chair Lina Khan from insulin case because of alleged bias
3 Dividend Growth Stocks Set to Supercharge Your Portfolio
3 Dividend Growth Stocks Set to Supercharge Your Portfolio
5 Relatively Secure And Cheap Dividend Stocks To Invest In -- October 2024
Will Cigna (CI) Beat Estimates Again in Its Next Earnings Report?
The Cigna Group's Third Quarter 2024 Earnings Release Details
Dividend Stocks With Strong Q4 Seasonality
CVS, Cigna unveil Medicare Advantage plans for 2025
Cigna Healthcare Offers Medicare Customers Value, Stability and Choice with 2025 Plans
Here's Why Cigna (CI) is a Strong Value Stock
The Cigna Group Issues 2024 Vitality In America Report, Revealing Increased Optimism Among Young Americans and Offering Insights on Workforce Health and Engagement
Cigna: This Dividend Grower Could Be Worth Buying Now
Are CVS Health, Cigna, and UnitedHealth Group Stocks Bad News Buys With the FTC's PBM Crackdown?
Our Top 10 Dividend Growth Stocks - September 2024
UnitedHealth Vs. CVS Vs. Cigna: Which Health Stock Will Beat The FTC's Regulatory Heat?
Pharmacy benefit managers respond to FTC's lawsuit over insulin drug prices
Express Scripts Comments on FTC's Reckless Insulin Action
FTC sues prescription-drug middlemen over insulin prices, says drugmakers are also ‘on notice'
FTC Sues CVS, Cigna, UnitedHealth Over Insulin Costs
Explainer: Why are US pharmacy benefit managers under fire?
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.